Envoy Medical, Inc.
COCH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -46.2% | 69.6% | 9.5% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -383.3% | -200% | -391.3% | -273.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -14,131% | -6,385.9% | -9,656.5% | -9,966.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -15,433.3% | -7,294.9% | -10,865.2% | -10,995.2% |
| EPS Diluted | -0.35 | -0.32 | -0.29 | -0.36 |
| % Growth | -9.4% | -10.3% | 19.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |